-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna To Present Three Abstracts On Intismeran Autogene At European Society For Medical Oncology Congress 2026

Benzinga·09/21/2026 14:13:43
Listen to the news

Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on intismeran autogene, an investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026, which will be held October 23-27 in Madrid, Spain.